Advertisement

Estrogens in Alzheimer’s Disease: A Clinical and Neurobiological Perspective

  • Peter Schönknecht
  • Johannes Pantel
  • Aoife Hunt
  • Marcus Henze
  • Thomas Strowitzki
  • Johannes Schröder

Keywords

Amyloid Precursor Protein Estrogen Replacement Therapy Quantitative Magnetic Resonance Imaging Amyloid Precursor Protein Metabolism Neurobiological Perspective 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Asthana A, Baker LD, Craft S, Stanczyk FZ, Veith RC, Raskind MA, Plymate SR (2001) High-dose estradiol improves cognition for women with AD. Neurology 57: 605–612PubMedGoogle Scholar
  2. Asthana S, Craft S, Baker LD, Raskind MA, Birnbaum RS, Lofgreen CP, Veith RC, Plymate SR (1999) Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal woman with Alzheimer’s disease: results of a placebo-controlled, double-blind, pilot study. Psychoneuroendocrino 24: 657–677Google Scholar
  3. Behl C, Skutella T, Lezoualch F, Post A, Widmann M, Newton CJ, Holsboer F (1997) Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51: 535–541PubMedGoogle Scholar
  4. Beyreuther K, Multhaupt G, Masters CL (1996) Molecular neuropathology in the causation of Alzheimer’s disease. In: Stefanis C, Hippius H (eds) Neuropsychiatry in Old Age: An Update. Hogrefe and Huber Publishers, Seattle Toronto Bern Göttingen, 43–54Google Scholar
  5. Bhathena RK, Anklesaria BS, Ganatra AM, Pinto R (1998) The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins. Br J Pharmacol 45: 170–172Google Scholar
  6. Bishop J, Simpkins JW (1992) Role of estrogens in peripheral and cerebral glucose utilization. Rev Neurosci 3: 121–137Google Scholar
  7. Buerger K, Zinkowski R, Teipel SJ, Tapiola T, Arai H, Blennow K, Andreasen N, Hofmann-Kiefer K, DeBernardis J, Kerkman D, McCulloch C, Kohnken R, Padberg F, Pirttilä T, Schapiro MB, Rapoport SI, Möller HJ, Davies P, Hampel H (2002) Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch Neurol 59: 1267–1272PubMedCrossRefGoogle Scholar
  8. Cheng CM, Cohen M, Wang J, Bondy CA (2001) Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. FASEB J 15: 907–915PubMedCrossRefGoogle Scholar
  9. Cunningham CJ, Sinnott M, Denihan A, Rowan M, Walsh JB, O'Moore R, Coakley D, Coen RF, Lawler BA, O'Neill DD (2001) Endogenous sex hormone levels in postmenopausal women with Alzheimer’s disease. J Clin Endocrinol Metab 86: 1099–1103PubMedCrossRefGoogle Scholar
  10. Fillit H (1994) Estrogens in the pathogenesis and treatment of Alzheimer’s disease in postmenopausal women. Ann NY Acad Sci 743: 233–238PubMedGoogle Scholar
  11. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. Psychiatr Res 12: 189–198Google Scholar
  12. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ (1995) Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 2:189–210Google Scholar
  13. Haass C, Selkoe DJ (1993) Cellular processing of ß-amyloid precursor protein and genesis of the amyloid-ß peptide. Cell 75: 1039–1042PubMedCrossRefGoogle Scholar
  14. Henderson V (1997a) Estrogen replacement therapy for the prevention and treatment of Alzheimer’s disease. CNS Drugs 8: 343–351Google Scholar
  15. Henderson VW (1997b) The epidemiology of estrogen replacement therapy and Alzheimer’s disease. Neurology 48: 27–35Google Scholar
  16. Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, McCleary CA, Klein RA, Hake AM, Farlow MR (2000) Estrogen for Alzheimer’s disease in woman: randomized, double-blind, placebo-controlled trial. Neurology 54: 295–301PubMedGoogle Scholar
  17. Hogervorst E, Smith D (2002) The interaction of serum folate and estradiol levels in Alzheimer’s disease. Neuroendocrinol Lett 23: 155–160PubMedGoogle Scholar
  18. Honjo H, Ogino Y, Naitoh K, Urabe M, Kitawaki J, Yasuda J, Yamamoto T, Ishihara S, Okada H, Yonezawa T, Hayashi K, Nambara T (1989) In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer’s type). J Steroid Biochem 34: 521–525PubMedGoogle Scholar
  19. Honjo H, Ogino Y, Tanaka K et al. (1993) An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer’s type: a placebo controlled, double-blind study. J Japan Menopause Soc 1: 167–171Google Scholar
  20. Ida N, Hartmann T, Pantel J, Schröder J, Zerfass R, Förstl H, Sandbrink R, Masters CL, Beyreuther K (1996) Analysis of heterogeneous ßA4 peptides in cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J Biol Chem 271: 22908–22914PubMedGoogle Scholar
  21. Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE (1994) Estrogen regulates metabolism of Alzheimer amyloid ß precursor protein. J Biol Chem 269: 13065–13068PubMedGoogle Scholar
  22. Jensen M, Schröder J, Blomberg M, Engvall B, Pantel J, Basun H, Wahlund LO, Werle E, Jauss M, Beyreuther K, Lannfelt L, Hartmann T (1999) Cerebrospinal fluid A beta 42 is increased early in sporadic Alzheimer’s disease and declines with disease progression. Ann Neurol 45: 504–511PubMedCrossRefGoogle Scholar
  23. Johnson JK, McCleary R, Oshita MH, Cotman CW (1998) Initiation and propagation stages of beta-amyloid are associated with distinctive apolipoprotein E, age, and gender profiles. Brain Res 798: 18–24PubMedCrossRefGoogle Scholar
  24. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zondermann A, Bacal C, Donnell Lingle D, Metter E (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: The Baltimore Longitudinal Study of Aging. Neurology 48: 1517–1521PubMedGoogle Scholar
  25. Lamberts SWJ, van den Beld AW, van der Lely AJ (1997) The endrocinology of aging. Science 278: 419–424PubMedCrossRefGoogle Scholar
  26. Lannert H, Wirtz P, Schuhmann V, Galmbacher R (1998) Effects of Estradiol (−17β) on learning, memory and cerebral energy metabolism in male rats after intracerebroventricular administration of streptozotocin. J Neuronal Transm 105: 1045–1063Google Scholar
  27. Lim SK, Won YJ, Lee JH, Kwon AH, Lee EJ, Kim KR, Lee HC, Huh KB, Chung BC (1997) Altered hydroxylation of estrogen in patients with postmenopausal osteopenia. J Clin Endocrinol Metab 82: 1001–1006PubMedCrossRefGoogle Scholar
  28. Luine V (1985) Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 89: 484–490PubMedCrossRefGoogle Scholar
  29. Lustig RH (1994) Sex hormone modulation of nerual development in vitro. Hormon Behav 28: 383–395CrossRefGoogle Scholar
  30. Maki PM, Resnick SM (2000) Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging 21: 373–383PubMedCrossRefGoogle Scholar
  31. Maki PM, Resnick SM (2001) Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. Neuroimage 14: 789–801PubMedCrossRefGoogle Scholar
  32. Manly JJ, Merchant CA, Jacobs DM, Small SA, Bell K, Ferin M, Mayeux R (2000) Endogenous estrogen levels and Alzheimer’s disease among postmenopausal women. Neurology 54: 833–837PubMedGoogle Scholar
  33. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of department of health an human services task force on Alzheimer’s disease. Neurology 34: 939–944PubMedGoogle Scholar
  34. Molnár G, Kassai-Bazsa Z (1997) Gonadotropin, ACTH, prolactin, sexual steroid and cortisol levels in postmenopausal women’s cerebrospinal fluid (CSF). Arch Gerontol Geriatr 24: 269–280PubMedGoogle Scholar
  35. Mooradian AD (1993) Antioxidant properties of steroids. J Steroid Biocgem Mol Biol 45: 509–511Google Scholar
  36. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundmann M, Thomas R, Thal LJ (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer’s disease: a randomized controlled trial. JAMA 283: 1007–1015PubMedCrossRefGoogle Scholar
  37. Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N (1995) Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports. Dementia 6: 99–107PubMedGoogle Scholar
  38. Ott BR, Heindl WC, Tan Z, Noto RB (2000) Lateralized cortical perfusion in woman with Alzheimer’s disease. J Gend Specif Med 3: 29–35PubMedGoogle Scholar
  39. Pantel J, Schröder J, Schad LR, Friedlinger M, Knopp MV, Schmitt R, Geißler M, Bluml S, Essig M, Sauer H (1997a) Quantitative magnetic resonace imaging and neuropsychological functions in dementia of the Alzheimer type. Psychol Med 27: 221–229PubMedCrossRefGoogle Scholar
  40. Pantel J, Schröder J, Essig M, Popp D, Dech H, Knopp MV, Schad LR, Eysenbach K, Backenstraß M, Friedlinger, M (1997b) Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia. J Affect Disord 42: 69–83PubMedCrossRefGoogle Scholar
  41. Petanceska S, Nagy V, Frail D, Gandy S (2000) Ovariectomy and 17β-estradiol modulate the levels of Alzheimer’s amyloid peptides in brain. Neurology 54: 2212–2217PubMedGoogle Scholar
  42. Schacter DL, Wagner AD (1999) Medial temporal lobe activations in fMRT and PET studies of episodic encoding and retrieval. Hippocampus 9: 7–24PubMedGoogle Scholar
  43. Schacter DL, Curran T, Reiman EM, Chen K, Bandy DJ, Frost JT (1999) Medial temporal lobe activation during episodic encoding and retrieval: a PET study. Hippocampus 9: 575–581PubMedGoogle Scholar
  44. Schneider J, Huh MM, Bradlow HL, Fishman J (1984) Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cells. J Biol Chem 259: 4840–4845PubMedGoogle Scholar
  45. Schönknecht P, Pantel J, Klinga K, Jensen M, Hartmann T, Salbach B, Schröder J (2001) Reduced cerebrospinal fluid estradiol levels are associated with increased ß-amyloid levels in female patients with Alzheimer’s disease. Neurosci Lett 307: 122–124PubMedGoogle Scholar
  46. Schönknecht P, Pantel J, Hartmann T, Werle E, Volkmann M, Essig M, Amann M, Zanabili N, Bardenheuer H, Hunt A, Schröder J (2002a) Cerebrospinal fluid tau levels in Alzheimer’s disease are elevated when compared to vascular dementia but do not correlate with measures of cerebral atrophy. Psychiatr Res (in press)Google Scholar
  47. Schönknecht P, Pantel J, Volkmann M, Hunt A, Schroeder J (2002b) Total and phosphorylated cerebrospinal fluid tau protein in Alzheimer’s disease and vascular dementia. Neurobiol Aging 23: S380Google Scholar
  48. Schönknecht P, Pantel J, Klinga K, Jensen M, Hartmann T, Beyreuther K, Schröder J (2002c) Cerebrospinal fluid estradiol and ß-amyloid levels in female patients with Alzheimer’s disease. Eur Psychiatry 17: 41sGoogle Scholar
  49. Schönknecht P, Henze M, Hunt A, Klinga K, Pantel J, Schröder J (2002d) Cerebrospinal fluid estrogen levels are associated with hippocampal glucose metabolism. Psychiatr Res: Neuroimaging (in press)Google Scholar
  50. Schröder J, Buchsbaum MS, Shihabuddin L, Tang C, Wei T, Spiegel-Cohen J, Hazlett EA, Abel L, Luu-Hsia C, Ciaravolo TM, Marin D, Davis KL (2001) Patterns of cortical activity and memory performance in Alzheimer’s disease. Biol Psychiatry 49: 426–436PubMedGoogle Scholar
  51. Schröder J, Pantel J (1999) Morphologische und funktionelle Bildgebung. In: Förstl H (ed) Alzheimer Demenz. Springer, Berlin Heidelberg New YorkGoogle Scholar
  52. Schröder J, Pantel J, Ida N, Essig M, Hartmann T, Knopp MV, Schad LR, Masters CL, Beyreuther K (1997) Cerebral changes and cerebrospinal fluid-amyloid in Alzheimer’s disease: a study with quantitative magnetic resonance imaging. Mol Psychiatry 2: 505–507PubMedGoogle Scholar
  53. Senanarong V, Vannasaeng S, Poungvarin N, Ploybutr S, Udompunthurak S, Jamjumras P, Fairbanks L, Cummings JL (2002) Endogenous estradiol in elderly individuals. Arch Neurol 59: 385–389PubMedCrossRefGoogle Scholar
  54. Talairach JA, Tournoux P (1988) Co-planar stereotaxic atlas of the human brain. Thieme, ParisGoogle Scholar
  55. Tang M, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R (1996) Effect of estrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet 348: 429–432PubMedCrossRefGoogle Scholar
  56. Urabe M, Yamamoto T, Kashiwagi T, Okubo T, Tsuchiya H, Iwasa K, Kikuchi N, Yokota K, Hosokawa K, Honjo H (1996) Effect of estrogen replacement therapy on hepatic triglyceride lipase, lipoprotein lipase and lipids including apolipoprotein E in climacteric and elderly women. Endocrinol J 43: 737–742Google Scholar
  57. Vandewalle B, Lefebvre J (1989) Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation. Mol Cell Endocrinol 61: 239–246PubMedCrossRefGoogle Scholar
  58. Wang PN, Liao SQ, Liu RS, Lin CY, Chao HT, Lu SR, Yu HY, Wang SJ, Lin HC (2000) Effects of estrogen on cognition, mood, and cerebral blood flow in AD. Neurology 54: 2061–2066PubMedGoogle Scholar
  59. Woolley CS, McEwen BS (1994) Estradiol regulates hippocampal dendritic spine density via na N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci 14: 7680–7687PubMedGoogle Scholar
  60. Xu H, Gouras GK, Greenfield JP, Vincent B, Naslund J, Mazzarelli L, Fried G, Jovanovic JN, Seeger M, Relkin NR, Liao F, Checler F, Buxbaum JD, Chait BT, Thinakaran G, Sisodia SS, Wang R, Greengard P, Gandy S (1998) Estrogen reduces neuronal generation of Alzheimer ß-amyloid peptides. Nature Med 4: 447–451PubMedGoogle Scholar
  61. Yaffe K, Grady D, Pressman A, Cummings S (1998) Serum estrone levels, cognitive performance, and risk of cognitive decline in older community women. J Am Geriatr Soc 46: 816–821PubMedGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2005

Authors and Affiliations

  • Peter Schönknecht
  • Johannes Pantel
  • Aoife Hunt
  • Marcus Henze
  • Thomas Strowitzki
  • Johannes Schröder

There are no affiliations available

Personalised recommendations